Company / EPS (Basic)
United Therapeutics EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$21.04
FY2025
5-year range
-$2.39 / $21.04
FY2021-FY2025
Trend
+31.7%
vs FY2024
Sector context
#3 of 208
Health Care
What the data says
Among 208 Health Care companies, United Therapeutics is in the top 1% for eps (basic). EPS (Basic) has fluctuated over the past 10 years, ranging from $-2.39 in FY2021 to $21.04 in FY2025.
Based on SEC 10-K filings.
21.04 in FY2025 with a 5-year CAGR of +9.2%. Ranks 3rd among 208 companies in Health Care.
Improved from $10.60 to $21.04 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 208This company $21.04 Sector average -$0.87
▼
+2516.7% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 31.7% year-over-year.
- Ranks #3 out of 208 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.04 | +31.7% |
| FY2024 | $15.98 | +50.8% |
| FY2023 | $10.60 | -9.0% |
| FY2022 | $11.65 | +587.4% |
| FY2021 | -$2.39 | -117.7% |
| FY2020 | $13.54 | +42.5% |
| FY2019 | $9.50 | -41.7% |
| FY2018 | $16.29 | +15.0% |
| FY2017 | $14.17 | +100.7% |
| FY2016 | $7.06 | +102.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026